𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pulmonary hypertension and thalidomide therapy in multiple myeloma

✍ Scribed by Hattori, Yutaka ;Shimoda, Masayuki ;Okamoto, Shinichiro ;Satoh, Toru ;Kakimoto, Tsunayuki ;Ikeda, Yasuo

Book ID
108673079
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
389 KB
Volume
128
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thalidomide treatment in multiple myelom
Thalidomide treatment in multiple myeloma
✍ Kathrin Strasser; Heinz Ludwig 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Thalidomide was first evaluated in patients with refractory multiple myeloma in the mid-90s. Based on the promising results achieved in these patients, the drug was subsequently used in earlier stages of the disease. Meanwhile, numerous phase II studies have been published using different doses and

Thalidomide–dexamethasone as primary the
Thalidomide–dexamethasone as primary therapy for advanced multiple myeloma
✍ Michael Wang; Donna M. Weber; Kay Delasalle; Raymond Alexanian 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views

## Abstract The value of thalidomide–dexamethasone was assessed in 26 consecutive, previously untreated patients with multiple myeloma of high tumor mass. All showed Hgb < 8.5 g/dL, serum calcium > 11.5 mg/dL, or both. The response rate was 73%, frequency of early death < 3 months was 5%, projected